Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study Article Swipe
Axel Le Cesne
,
Christine Chevreau
,
Christophe Perrin
,
Antoîne Italiano
,
Alice Hervieu
,
Jean‐Yves Blay
,
Sophie Piperno‐Neumann
,
Esma Saâda-Bouzid
,
François Bertucci
,
Nelly Firmin
,
Elsa Kalbacher
,
B. Narciso
,
Camille Schiffler
,
Sabrina Yara
,
Marta Jimenez
,
Corinne Bouvier
,
Vincent Vidal
,
Sylvie Chabaud
,
Florence Duffaud
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.esmoop.2023.101569
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.esmoop.2023.101569
This study failed to show any signal of benefit for regorafenib in patients with advanced/metastatic recurrent chordoma.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.esmoop.2023.101569
- http://www.esmoopen.com/article/S2059702923008001/pdf
- OA Status
- gold
- Cited By
- 12
- References
- 22
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4379646061
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4379646061Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.esmoop.2023.101569Digital Object Identifier
- Title
-
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-06-01Full publication date if available
- Authors
-
Axel Le Cesne, Christine Chevreau, Christophe Perrin, Antoîne Italiano, Alice Hervieu, Jean‐Yves Blay, Sophie Piperno‐Neumann, Esma Saâda-Bouzid, François Bertucci, Nelly Firmin, Elsa Kalbacher, B. Narciso, Camille Schiffler, Sabrina Yara, Marta Jimenez, Corinne Bouvier, Vincent Vidal, Sylvie Chabaud, Florence DuffaudList of authors in order
- Landing page
-
https://doi.org/10.1016/j.esmoop.2023.101569Publisher landing page
- PDF URL
-
https://www.esmoopen.com/article/S2059702923008001/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.esmoopen.com/article/S2059702923008001/pdfDirect OA link when available
- Concepts
-
Regorafenib, Medicine, Placebo, Clinical endpoint, Internal medicine, Surgery, Randomized controlled trial, Colorectal cancer, Cancer, Pathology, Alternative medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
12Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5, 2024: 5, 2023: 2Per-year citation counts (last 5 years)
- References (count)
-
22Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4379646061 |
|---|---|
| doi | https://doi.org/10.1016/j.esmoop.2023.101569 |
| ids.doi | https://doi.org/10.1016/j.esmoop.2023.101569 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37285716 |
| ids.openalex | https://openalex.org/W4379646061 |
| fwci | 4.92449334 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D008297 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Male |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000368 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Aged |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005260 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Female |
| mesh[4].qualifier_ui | Q000188 |
| mesh[4].descriptor_ui | D002817 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | drug therapy |
| mesh[4].descriptor_name | Chordoma |
| mesh[5].qualifier_ui | Q000139 |
| mesh[5].descriptor_ui | D002817 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | chemically induced |
| mesh[5].descriptor_name | Chordoma |
| mesh[6].qualifier_ui | Q000009 |
| mesh[6].descriptor_ui | D010671 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | adverse effects |
| mesh[6].descriptor_name | Phenylurea Compounds |
| mesh[7].qualifier_ui | Q000494 |
| mesh[7].descriptor_ui | D011725 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | pharmacology |
| mesh[7].descriptor_name | Pyridines |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D011725 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Pyridines |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000077982 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Progression-Free Survival |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D008297 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Male |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000368 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Aged |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D005260 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Female |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D002817 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Chordoma |
| mesh[15].qualifier_ui | Q000139 |
| mesh[15].descriptor_ui | D002817 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | chemically induced |
| mesh[15].descriptor_name | Chordoma |
| mesh[16].qualifier_ui | Q000009 |
| mesh[16].descriptor_ui | D010671 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | adverse effects |
| mesh[16].descriptor_name | Phenylurea Compounds |
| mesh[17].qualifier_ui | Q000494 |
| mesh[17].descriptor_ui | D011725 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | pharmacology |
| mesh[17].descriptor_name | Pyridines |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D011725 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Pyridines |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000077982 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Progression-Free Survival |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D008297 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Male |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000368 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Aged |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D005260 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Female |
| mesh[24].qualifier_ui | Q000188 |
| mesh[24].descriptor_ui | D002817 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | drug therapy |
| mesh[24].descriptor_name | Chordoma |
| mesh[25].qualifier_ui | Q000139 |
| mesh[25].descriptor_ui | D002817 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | chemically induced |
| mesh[25].descriptor_name | Chordoma |
| mesh[26].qualifier_ui | Q000009 |
| mesh[26].descriptor_ui | D010671 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | adverse effects |
| mesh[26].descriptor_name | Phenylurea Compounds |
| mesh[27].qualifier_ui | Q000494 |
| mesh[27].descriptor_ui | D011725 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | pharmacology |
| mesh[27].descriptor_name | Pyridines |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D011725 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Pyridines |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000077982 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Progression-Free Survival |
| type | article |
| title | Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study |
| biblio.issue | 3 |
| biblio.volume | 8 |
| biblio.last_page | 101569 |
| biblio.first_page | 101569 |
| topics[0].id | https://openalex.org/T10975 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2745 |
| topics[0].subfield.display_name | Rheumatology |
| topics[0].display_name | Bone Tumor Diagnosis and Treatments |
| topics[1].id | https://openalex.org/T10253 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Sarcoma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T11787 |
| topics[2].field.id | https://openalex.org/fields/35 |
| topics[2].field.display_name | Dentistry |
| topics[2].score | 0.9832000136375427 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3504 |
| topics[2].subfield.display_name | Oral Surgery |
| topics[2].display_name | Oral and Maxillofacial Pathology |
| is_xpac | False |
| apc_list.value | 2750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2965 |
| apc_paid.value | 2750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2965 |
| concepts[0].id | https://openalex.org/C2776248978 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9778790473937988 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q3891664 |
| concepts[0].display_name | Regorafenib |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8817284107208252 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C27081682 |
| concepts[2].level | 3 |
| concepts[2].score | 0.711114764213562 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[2].display_name | Placebo |
| concepts[3].id | https://openalex.org/C203092338 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6658573150634766 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[3].display_name | Clinical endpoint |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5833431482315063 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C141071460 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5688508749008179 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[5].display_name | Surgery |
| concepts[6].id | https://openalex.org/C168563851 |
| concepts[6].level | 2 |
| concepts[6].score | 0.27073752880096436 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[6].display_name | Randomized controlled trial |
| concepts[7].id | https://openalex.org/C526805850 |
| concepts[7].level | 3 |
| concepts[7].score | 0.08793944120407104 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[7].display_name | Colorectal cancer |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.08555927872657776 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C142724271 |
| concepts[9].level | 1 |
| concepts[9].score | 0.056495606899261475 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[9].display_name | Pathology |
| concepts[10].id | https://openalex.org/C204787440 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[10].display_name | Alternative medicine |
| keywords[0].id | https://openalex.org/keywords/regorafenib |
| keywords[0].score | 0.9778790473937988 |
| keywords[0].display_name | Regorafenib |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8817284107208252 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/placebo |
| keywords[2].score | 0.711114764213562 |
| keywords[2].display_name | Placebo |
| keywords[3].id | https://openalex.org/keywords/clinical-endpoint |
| keywords[3].score | 0.6658573150634766 |
| keywords[3].display_name | Clinical endpoint |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5833431482315063 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/surgery |
| keywords[5].score | 0.5688508749008179 |
| keywords[5].display_name | Surgery |
| keywords[6].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[6].score | 0.27073752880096436 |
| keywords[6].display_name | Randomized controlled trial |
| keywords[7].id | https://openalex.org/keywords/colorectal-cancer |
| keywords[7].score | 0.08793944120407104 |
| keywords[7].display_name | Colorectal cancer |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.08555927872657776 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/pathology |
| keywords[9].score | 0.056495606899261475 |
| keywords[9].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1016/j.esmoop.2023.101569 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210217024 |
| locations[0].source.issn | 2059-7029 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2059-7029 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | ESMO Open |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | http://www.esmoopen.com/article/S2059702923008001/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ESMO Open |
| locations[0].landing_page_url | https://doi.org/10.1016/j.esmoop.2023.101569 |
| locations[1].id | pmid:37285716 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | ESMO open |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37285716 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10265601 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc-nd |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10265601/pdf/main.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | ESMO Open |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10265601 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5090103193 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8006-8659 |
| authorships[0].author.display_name | Axel Le Cesne |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2801843802 |
| authorships[0].affiliations[0].raw_affiliation_string | Medical Oncology Department, Gustave Roussy, Villejuif |
| authorships[0].institutions[0].id | https://openalex.org/I2801843802 |
| authorships[0].institutions[0].ror | https://ror.org/0321g0743 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I2801843802 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Institut Gustave Roussy |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | A. Le Cesne |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Medical Oncology Department, Gustave Roussy, Villejuif |
| authorships[1].author.id | https://openalex.org/A5103187243 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9866-913X |
| authorships[1].author.display_name | Christine Chevreau |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210098740 |
| authorships[1].affiliations[0].raw_affiliation_string | Medical Oncology Department, Institut Universitaire de Cancérologie de Toulouse, Oncopole, Toulouse |
| authorships[1].institutions[0].id | https://openalex.org/I4210098740 |
| authorships[1].institutions[0].ror | https://ror.org/014hxhm89 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210098740 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Institut universitaire du cancer de Toulouse Oncopole |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | C. Chevreau |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Medical Oncology Department, Institut Universitaire de Cancérologie de Toulouse, Oncopole, Toulouse |
| authorships[2].author.id | https://openalex.org/A5066221687 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2989-5296 |
| authorships[2].author.display_name | Christophe Perrin |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210110881 |
| authorships[2].affiliations[0].raw_affiliation_string | Medical Oncology Unit, Centre Eugène Marquis, Rennes |
| authorships[2].institutions[0].id | https://openalex.org/I4210110881 |
| authorships[2].institutions[0].ror | https://ror.org/01yezas83 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210110881 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Centre Eugène Marquis |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | C. Perrin |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Medical Oncology Unit, Centre Eugène Marquis, Rennes |
| authorships[3].author.id | https://openalex.org/A5060949051 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8540-5351 |
| authorships[3].author.display_name | Antoîne Italiano |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210134409 |
| authorships[3].affiliations[0].raw_affiliation_string | Medical Oncology Department, Institut Bergonié, Bordeaux |
| authorships[3].institutions[0].id | https://openalex.org/I4210134409 |
| authorships[3].institutions[0].ror | https://ror.org/02yw1f353 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210134409 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Institut Bergonié |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | A. Italiano |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Medical Oncology Department, Institut Bergonié, Bordeaux |
| authorships[4].author.id | https://openalex.org/A5053571734 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Alice Hervieu |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210094685 |
| authorships[4].affiliations[0].raw_affiliation_string | Medical Oncology Department, Centre Georges Francois Leclerc, Dijon |
| authorships[4].institutions[0].id | https://openalex.org/I4210094685 |
| authorships[4].institutions[0].ror | https://ror.org/00pjqzf38 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210094685, https://openalex.org/I4210141925 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Centre Georges François Leclerc |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | A. Hervieu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Medical Oncology Department, Centre Georges Francois Leclerc, Dijon |
| authorships[5].author.id | https://openalex.org/A5042202815 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-7190-120X |
| authorships[5].author.display_name | Jean‐Yves Blay |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210105738 |
| authorships[5].affiliations[0].raw_affiliation_string | Medical Oncology Department, Centre Léon Bérard, Lyons |
| authorships[5].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[5].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Centre Léon Bérard |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | J.Y. Blay |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Medical Oncology Department, Centre Léon Bérard, Lyons |
| authorships[6].author.id | https://openalex.org/A5003536346 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-9915-2810 |
| authorships[6].author.display_name | Sophie Piperno‐Neumann |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I80043 |
| authorships[6].affiliations[0].raw_affiliation_string | Medical Oncology Department, Institut Curie, Paris |
| authorships[6].institutions[0].id | https://openalex.org/I80043 |
| authorships[6].institutions[0].ror | https://ror.org/04t0gwh46 |
| authorships[6].institutions[0].type | nonprofit |
| authorships[6].institutions[0].lineage | https://openalex.org/I80043 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Institut Curie |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | S. Piperno-Neumann |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Medical Oncology Department, Institut Curie, Paris |
| authorships[7].author.id | https://openalex.org/A5108780490 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Esma Saâda-Bouzid |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210151846 |
| authorships[7].affiliations[0].raw_affiliation_string | Medical Oncology Department, Centre Antoine Lacassagne, Nice |
| authorships[7].institutions[0].id | https://openalex.org/I4210151846 |
| authorships[7].institutions[0].ror | https://ror.org/05hmfw828 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210151846 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Centre Antoine Lacassagne |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | E. Saada-Bouzid |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Medical Oncology Department, Centre Antoine Lacassagne, Nice |
| authorships[8].author.id | https://openalex.org/A5091721810 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-0157-0959 |
| authorships[8].author.display_name | François Bertucci |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210150365 |
| authorships[8].affiliations[0].raw_affiliation_string | Medical Oncology Department, Institut Paoli Calmettes, Marseille |
| authorships[8].institutions[0].id | https://openalex.org/I4210150365 |
| authorships[8].institutions[0].ror | https://ror.org/04s3t1g37 |
| authorships[8].institutions[0].type | nonprofit |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210150365 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Institut Paoli-Calmettes |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | F. Bertucci |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Medical Oncology Department, Institut Paoli Calmettes, Marseille |
| authorships[9].author.id | https://openalex.org/A5037214360 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-5839-6261 |
| authorships[9].author.display_name | Nelly Firmin |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210147367 |
| authorships[9].affiliations[0].raw_affiliation_string | Medical Oncologie Department, Centre Valdorelle, Montpellier |
| authorships[9].institutions[0].id | https://openalex.org/I4210147367 |
| authorships[9].institutions[0].ror | https://ror.org/03fkrcm40 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210088668, https://openalex.org/I4210147367 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Centre Occitanie-Montpellier |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | N. Firmin |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Medical Oncologie Department, Centre Valdorelle, Montpellier |
| authorships[10].author.id | https://openalex.org/A5080907817 |
| authorships[10].author.orcid | https://orcid.org/0009-0004-0497-8521 |
| authorships[10].author.display_name | Elsa Kalbacher |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210087978 |
| authorships[10].affiliations[0].raw_affiliation_string | Medical Oncology Department, CHU J Minjoz, Besançon |
| authorships[10].institutions[0].id | https://openalex.org/I4210087978 |
| authorships[10].institutions[0].ror | https://ror.org/0084te143 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210087978 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Centre Hospitalier Universitaire de Besançon |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | E. Kalbacher |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Medical Oncology Department, CHU J Minjoz, Besançon |
| authorships[11].author.id | https://openalex.org/A5112648030 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | B. Narciso |
| authorships[11].countries | FR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210100159, https://openalex.org/I4210095477 |
| authorships[11].affiliations[0].raw_affiliation_string | Medical Oncology Department, CHU Bretonneau, Tours |
| authorships[11].institutions[0].id | https://openalex.org/I4210095477 |
| authorships[11].institutions[0].ror | https://ror.org/00jpq0w62 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210095477 |
| authorships[11].institutions[0].country_code | FR |
| authorships[11].institutions[0].display_name | Centre Hospitalier Universitaire de Tours |
| authorships[11].institutions[1].id | https://openalex.org/I4210100159 |
| authorships[11].institutions[1].ror | https://ror.org/0146pps37 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210100159 |
| authorships[11].institutions[1].country_code | FR |
| authorships[11].institutions[1].display_name | Hôpital Bretonneau |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | B. Narciso |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Medical Oncology Department, CHU Bretonneau, Tours |
| authorships[12].author.id | https://openalex.org/A5050433884 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-0633-8988 |
| authorships[12].author.display_name | Camille Schiffler |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210105738 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Statistics, Centre Léon Bérard, Lyons |
| authorships[12].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[12].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[12].institutions[0].type | nonprofit |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Centre Léon Bérard |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | C. Schiffler |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Statistics, Centre Léon Bérard, Lyons |
| authorships[13].author.id | https://openalex.org/A5006917974 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Sabrina Yara |
| authorships[13].countries | FR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210141925 |
| authorships[13].affiliations[0].raw_affiliation_string | Unicancer, Paris |
| authorships[13].institutions[0].id | https://openalex.org/I4210141925 |
| authorships[13].institutions[0].ror | https://ror.org/04vhgtv41 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210141925 |
| authorships[13].institutions[0].country_code | FR |
| authorships[13].institutions[0].display_name | UniCancer Group |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | S. Yara |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Unicancer, Paris |
| authorships[14].author.id | https://openalex.org/A5076243488 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-4233-8478 |
| authorships[14].author.display_name | Marta Jimenez |
| authorships[14].countries | FR |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210141925 |
| authorships[14].affiliations[0].raw_affiliation_string | Unicancer, Paris |
| authorships[14].institutions[0].id | https://openalex.org/I4210141925 |
| authorships[14].institutions[0].ror | https://ror.org/04vhgtv41 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210141925 |
| authorships[14].institutions[0].country_code | FR |
| authorships[14].institutions[0].display_name | UniCancer Group |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | M. Jimenez |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Unicancer, Paris |
| authorships[15].author.id | https://openalex.org/A5111526772 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Corinne Bouvier |
| authorships[15].countries | FR |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210162909 |
| authorships[15].affiliations[0].raw_affiliation_string | Aix Marseille Univ, APHM Hopital La Timone, Pathology Department, Marseille |
| authorships[15].institutions[0].id | https://openalex.org/I4210162909 |
| authorships[15].institutions[0].ror | https://ror.org/05jrr4320 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210087487, https://openalex.org/I4210162909 |
| authorships[15].institutions[0].country_code | FR |
| authorships[15].institutions[0].display_name | Hôpital de la Timone |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | C. Bouvier |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Aix Marseille Univ, APHM Hopital La Timone, Pathology Department, Marseille |
| authorships[16].author.id | https://openalex.org/A5077797776 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-1680-3986 |
| authorships[16].author.display_name | Vincent Vidal |
| authorships[16].affiliations[0].raw_affiliation_string | Aix Marseille Univ, APHM Hopital La Timone, Radiology Department, Marseille |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | V. Vidal |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Aix Marseille Univ, APHM Hopital La Timone, Radiology Department, Marseille |
| authorships[17].author.id | https://openalex.org/A5048784388 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-4655-6867 |
| authorships[17].author.display_name | Sylvie Chabaud |
| authorships[17].countries | FR |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210105738 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Statistics, Centre Léon Bérard, Lyons |
| authorships[17].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[17].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[17].institutions[0].type | nonprofit |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[17].institutions[0].country_code | FR |
| authorships[17].institutions[0].display_name | Centre Léon Bérard |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | S. Chabaud |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Statistics, Centre Léon Bérard, Lyons |
| authorships[18].author.id | https://openalex.org/A5065856111 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-2057-3557 |
| authorships[18].author.display_name | Florence Duffaud |
| authorships[18].countries | FR |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I21491767 |
| authorships[18].affiliations[0].raw_affiliation_string | Aix Marseille University (AMU), APHM Hopital La Timone, Medical Oncology Unit, APHM, Marseille, France |
| authorships[18].institutions[0].id | https://openalex.org/I21491767 |
| authorships[18].institutions[0].ror | https://ror.org/035xkbk20 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I21491767 |
| authorships[18].institutions[0].country_code | FR |
| authorships[18].institutions[0].display_name | Aix-Marseille Université |
| authorships[18].author_position | last |
| authorships[18].raw_author_name | F. Duffaud |
| authorships[18].is_corresponding | True |
| authorships[18].raw_affiliation_strings | Aix Marseille University (AMU), APHM Hopital La Timone, Medical Oncology Unit, APHM, Marseille, France |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.esmoopen.com/article/S2059702923008001/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10975 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2745 |
| primary_topic.subfield.display_name | Rheumatology |
| primary_topic.display_name | Bone Tumor Diagnosis and Treatments |
| related_works | https://openalex.org/W2314601331, https://openalex.org/W2811168026, https://openalex.org/W2319024198, https://openalex.org/W4293577346, https://openalex.org/W2624771607, https://openalex.org/W2054301472, https://openalex.org/W2190778458, https://openalex.org/W4380224996, https://openalex.org/W2125893749, https://openalex.org/W2506157358 |
| cited_by_count | 12 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 5 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1016/j.esmoop.2023.101569 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210217024 |
| best_oa_location.source.issn | 2059-7029 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2059-7029 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | ESMO Open |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | http://www.esmoopen.com/article/S2059702923008001/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | ESMO Open |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.esmoop.2023.101569 |
| primary_location.id | doi:10.1016/j.esmoop.2023.101569 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210217024 |
| primary_location.source.issn | 2059-7029 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2059-7029 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | ESMO Open |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | http://www.esmoopen.com/article/S2059702923008001/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ESMO Open |
| primary_location.landing_page_url | https://doi.org/10.1016/j.esmoop.2023.101569 |
| publication_date | 2023-06-01 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3197355167, https://openalex.org/W4235164524, https://openalex.org/W2586748258, https://openalex.org/W2337659464, https://openalex.org/W1983180167, https://openalex.org/W1968209756, https://openalex.org/W2537836937, https://openalex.org/W2101776780, https://openalex.org/W2901259053, https://openalex.org/W3159643156, https://openalex.org/W2796139873, https://openalex.org/W2120113475, https://openalex.org/W2941090871, https://openalex.org/W1988995169, https://openalex.org/W2889701300, https://openalex.org/W2112866395, https://openalex.org/W2144717536, https://openalex.org/W2529083835, https://openalex.org/W2170583701, https://openalex.org/W2611022823, https://openalex.org/W1986947159, https://openalex.org/W6796475286 |
| referenced_works_count | 22 |
| abstract_inverted_index.in | 11 |
| abstract_inverted_index.of | 7 |
| abstract_inverted_index.to | 3 |
| abstract_inverted_index.any | 5 |
| abstract_inverted_index.for | 9 |
| abstract_inverted_index.This | 0 |
| abstract_inverted_index.show | 4 |
| abstract_inverted_index.with | 13 |
| abstract_inverted_index.study | 1 |
| abstract_inverted_index.failed | 2 |
| abstract_inverted_index.signal | 6 |
| abstract_inverted_index.benefit | 8 |
| abstract_inverted_index.patients | 12 |
| abstract_inverted_index.chordoma. | 16 |
| abstract_inverted_index.recurrent | 15 |
| abstract_inverted_index.regorafenib | 10 |
| abstract_inverted_index.advanced/metastatic | 14 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5065856111 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 19 |
| corresponding_institution_ids | https://openalex.org/I21491767 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.93333905 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |